Advertisement
Screener

FORTREA HOLDINGS INC. (FTRE) EBITDA

FORTREA HOLDINGS INC. (FTRE) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $34.40M*; Operating income $14.80M; Depreciation and amortization $19.60M*.
  • 2026-03-31: Basis Reported; EBITDA $16.4M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $5.7M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA $11.00M*; Operating income -$8.60M; Depreciation and amortization $19.60M*.

Complete source-backed ebitda history.

Available history
2021-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$34.40M*$14.80M$19.60M*$678.20M5.07%*(m)$28.90M*(m)(m)$102.10M$12.00M
2026-03-31Reported$16.4M(m)(m)(m)2.58%(m)-$17.00M(m)(m)$100.50M$11.30M
2025-12-31Reported$5.7M(m)(m)(m)0.86%(m)(m)(m)(m)(m)(m)
2025-09-30Reported$11.00M*-$8.60M$19.60M*$701.30M1.57%*(m)$86.80M*(m)(m)$106.80M-$12.80M
2025-06-30Reported-$310.70M*-$330.30M$19.60M*$710.30M-43.74%*(m)$21.80M*(m)(m)$124.80M$4.20M
2025-03-31Reported-$500.6M(m)(m)(m)-76.86%(m)-$124.20M(m)(m)$121.80M$14.90M
2024-12-31Reported-$34.8M(m)(m)(m)-4.99%(m)(m)(m)(m)(m)(m)
2024-09-30Reported$3.20M*-$18.00M$21.20M*$674.90M0.47%*(m)-$2.40M*(m)(m)$136.30M-$17.30M
2024-06-30Reported-$29.50M*-$50.90M$21.40M*$662.40M-4.45%*(m)$273.70M*(m)(m)$156.20M$10.70M
2024-03-31Reported-$13.9M(m)(m)(m)-2.10%(m)-$25.60M(m)(m)$120.10M$4.10M
2023-12-31Reported$400,000.00(m)(m)(m)0.06%(m)(m)(m)(m)(m)(m)
2023-09-30Reported$34.9M(m)(m)(m)4.89%(m)$1.90M*(m)(m)$106.80M-$5.80M
2023-06-30Reported$56.7M(m)(m)(m)7.82%(m)$150.10M*(m)(m)$97.80M$11.60M
2023-03-31Reported$37.2M(m)(m)(m)5.36%(m)-$2.00M(m)(m)$116.80M$1.50M
2022-12-31Reported$38.2M(m)(m)(m)7.60%(m)(m)(m)(m)(m)(m)
2022-09-30Reported$91.6M(m)(m)(m)12.02%(m)$80.90M*(m)(m)$70.70M$13.60M
2022-06-30Reported$94.6M(m)(m)(m)11.93%(m)(m)(m)(m)$71.20M$17.20M

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$794.6M(m)(m)(m)-29.18%(m)$113.50M(m)(m)$456.40M$3.20M
2024-12-31Reported-$75M(m)(m)(m)-2.78%(m)$262.80M(m)(m)$560.70M-$3.50M
2023-12-31Reported$130M(m)(m)(m)4.57%(m)$168.40M(m)(m)$448.10M$1.20M
2022-12-31Reported$280.7M(m)(m)(m)9.89%(m)$82.70M(m)(m)$416.10M$41.10M
2021-12-31Reported$280.6M(m)(m)(m)9.18%(m)$169.80M(m)(m)$303.10M$38.40M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CareDx, Inc. (CDNA)United States$3.174B13.21
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64